{
    "body_text": [
        {
            "endOffset": 12217,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Robert W. Sauerwein declares no conflict of interest; Thomas L. Richie is a salaried, full time employee of Sanaria Inc., the developer and sponsor of Sanaria PfSPZ Vaccine, PfSPZ Challenge, and the PfSPZ-CVac vaccine approach.",
            "startOffset": 11990,
            "title": "Conflict of interest statement"
        }
    ],
    "docId": "S0264410X15015480",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "R. W.",
                "initial": "R.W.",
                "last": "Sauerwein"
            },
            {
                "email": null,
                "first": "T. L.",
                "initial": "T.L.",
                "last": "Richie"
            }
        ],
        "doi": "10.1016/j.vaccine.2015.10.092",
        "firstpage": "7423",
        "issn": "0264410X",
        "lastpage": "7424",
        "openaccess": "Full",
        "pub_year": 2015,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Malaria vaccines getting close to clinical reality"
    }
}